HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VU0466551

activator of G protein-gated inwardly rectifying potassium (GIRK) channels

Also Known As:

1-(2-benzyl-5-methylpyrazol-3-yl)-3-(3,4-difluorophenyl)urea

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Urea: 15015
    - Phenylurea Compounds: 1
      - VU0466551: 2
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenylurea Compounds: 1
        VU0466551: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - VU0466551: 2

Experts

1.	Abney, Kristopher K: 2 articles (05/2019 - 01/2019)
2.	Bridges, Thomas M: 2 articles (05/2019 - 01/2019)
3.	Bubser, Michael: 2 articles (05/2019 - 01/2019)
4.	Daniels, J Scott: 2 articles (05/2019 - 01/2019)
5.	Du, Yu: 2 articles (05/2019 - 01/2019)
6.	Hopkins, Corey R: 2 articles (05/2019 - 01/2019)
7.	Jones, Carrie K: 2 articles (05/2019 - 01/2019)
8.	Kozek, Krystian A: 2 articles (05/2019 - 01/2019)
9.	Morrison, Ryan D: 2 articles (05/2019 - 01/2019)
10.	Weaver, C David: 2 articles (05/2019 - 01/2019)

Related Diseases

1.	Pain (Aches) 05/15/2019 - "Correction to Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models." 01/01/2019 - "Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models."

Related Drugs and Biologics

1.	Morphine (MS Contin)
2.	Analgesics (Analgesic Drugs)